Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Unusually-High Trading Volume – What’s Next?

by · The Markets Daily

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) shares saw strong trading volume on Thursday . 271,047 shares changed hands during trading, an increase of 113% from the previous session’s volume of 127,418 shares.The stock last traded at $12.1967 and had previously closed at $11.72.

Analysts Set New Price Targets

Separately, Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a research note on Tuesday, June 23rd. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock has a consensus rating of “Buy”.

Read Our Latest Report on FSNUY

Fresenius SE & Co. Stock Up 3.1%

The firm has a market cap of $27.22 billion, a PE ratio of 16.11 and a beta of 0.63. The business’s 50 day moving average price is $11.41 and its 200 day moving average price is $13.10. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.27 and a quick ratio of 0.98.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.01). The company had revenue of $6.75 billion for the quarter, compared to analyst estimates of $6.79 billion. Fresenius SE & Co. had a return on equity of 10.09% and a net margin of 6.55%. On average, equities research analysts expect that Fresenius SE & Co. will post 1.03 earnings per share for the current year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.

See Also